tranexamic acid has been researched along with Hematoma, Subdural, Chronic in 16 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Hematoma, Subdural, Chronic: Accumulation of blood in the SUBDURAL SPACE with delayed onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tranexamic acid (TXA) has been hypothesized as an oral agent to avoid CSDH progression and/or recurrence." | 3.30 | Effect of postoperative tranexamic acid on recurrence rate and complications in chronic subdural hematomas patients: preliminary results of a randomized controlled clinical trial. ( de Freitas, PVV; de Oliveira, MF; de Paula, MVCT; Melo, MM; Pahl, FH; Ribeiro, BDC; Rotta, JM, 2023) |
| "A total of 297 patients with chronic subdural hematoma underwent initial burr hole surgery at our hospital from April 2014 to March 2018." | 2.94 | Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery. ( Natori, Y; Yamada, T, 2020) |
| " Secondary endpoints were comparison of post-operative volumes between the treatment arms and safety evaluation of the dosing regime." | 2.94 | An open label randomized trial to assess the efficacy of tranexamic acid in reducing post-operative recurrence of chronic subdural haemorrhage. ( Khong, WXL; King, NKK; Ng, WH; Ong, JCL; Qiu, L; Saffari, SE; See, AA; Wan, KR, 2020) |
| " All patients were given Txa in the dosage of 750 mg/day in divided doses." | 1.56 | The Outcome of Medical Management of Chronic Subdural Hematoma with Tranexamic Acid - A Prospective Observational Study. ( Asher, P; Kutty, RK; Leela, SK; Peethambaran, A; Prabhakar, RB; Sivanandapanicker, JL; Sreemathyamma, SB, 2020) |
| "BACKGROUND Chronic subdural hematoma (CSDH) is a common neurosurgical condition that is treated using a cranial burr hole evacuation procedure, but recurrence is common." | 1.46 | A Case of Tranexamic Acid as Adjunctive Treatment for Chronic Subdural Hematoma with Multiple Recurrences. ( Anker-Møller, T; Hvas, AM; Mikkelsen, R; Sunde, N, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 12 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Immenga, S | 2 |
| Lodewijkx, R | 2 |
| Roos, YBWEM | 1 |
| Middeldorp, S | 1 |
| Majoie, CBLM | 1 |
| Willems, HC | 1 |
| Vandertop, WP | 2 |
| Verbaan, D | 2 |
| Shibahashi, K | 1 |
| Ohbe, H | 1 |
| Yasunaga, H | 1 |
| de Paula, MVCT | 1 |
| Ribeiro, BDC | 1 |
| Melo, MM | 1 |
| de Freitas, PVV | 1 |
| Pahl, FH | 1 |
| de Oliveira, MF | 1 |
| Rotta, JM | 1 |
| Kumar, A | 1 |
| Arsal, SA | 1 |
| Shafique, MA | 1 |
| Yamada, T | 1 |
| Natori, Y | 1 |
| Scerrati, A | 1 |
| Visani, J | 1 |
| Ricciardi, L | 1 |
| Dones, F | 1 |
| Rustemi, O | 1 |
| Cavallo, MA | 1 |
| De Bonis, P | 1 |
| Kutty, RK | 2 |
| Leela, SK | 1 |
| Sreemathyamma, SB | 1 |
| Sivanandapanicker, JL | 1 |
| Asher, P | 1 |
| Peethambaran, A | 1 |
| Prabhakar, RB | 1 |
| Suresh, V | 1 |
| Sharma, S | 1 |
| Wan, KR | 1 |
| Qiu, L | 1 |
| Saffari, SE | 1 |
| Khong, WXL | 1 |
| Ong, JCL | 1 |
| See, AA | 1 |
| Ng, WH | 1 |
| King, NKK | 1 |
| Panda, PK | 1 |
| Sharawat, IK | 1 |
| van den Berg, R | 1 |
| Post, R | 1 |
| Westerink, LG | 1 |
| Nabuurs, RJA | 1 |
| Can, A | 1 |
| Mikkelsen, R | 1 |
| Anker-Møller, T | 1 |
| Hvas, AM | 1 |
| Sunde, N | 1 |
| Kageyama, H | 1 |
| Toyooka, T | 1 |
| Tsuzuki, N | 1 |
| Oka, K | 1 |
| Iorio-Morin, C | 1 |
| Blanchard, J | 1 |
| Richer, M | 1 |
| Mathieu, D | 1 |
| Wakabayashi, Y | 1 |
| Yamashita, M | 1 |
| Asano, T | 1 |
| Yamada, A | 1 |
| Kenai, H | 1 |
| Kondoh, Y | 1 |
| Hori, Y | 1 |
| Nagatomi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma. A Double-blind, Placebo-controlled, Multicentre, Randomized Controlled Clinical Trial[NCT03582293] | Phase 3 | 140 participants (Anticipated) | Interventional | 2018-06-19 | Recruiting | ||
| TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma[NCT05713630] | Phase 3 | 130 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| Tranexamic Acid in Chronic Subdural Hematomas[NCT02568124] | Phase 2/Phase 3 | 130 participants (Anticipated) | Interventional | 2015-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tranexamic acid and Hematoma, Subdural, Chronic
| Article | Year |
|---|---|
To drill or not to drill, that is the question: nonsurgical treatment of chronic subdural hematoma in the elderly. A systematic review.
Topics: Aged; Embolization, Therapeutic; Hematoma, Subdural, Chronic; Humans; Meningeal Arteries; Tranexamic | 2020 |
6 trials available for tranexamic acid and Hematoma, Subdural, Chronic
| Article | Year |
|---|---|
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial.
Topics: Activities of Daily Living; Aged; Clinical Trials, Phase III as Topic; Hematoma, Subdural, Chronic; | 2022 |
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial.
Topics: Activities of Daily Living; Aged; Clinical Trials, Phase III as Topic; Hematoma, Subdural, Chronic; | 2022 |
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial.
Topics: Activities of Daily Living; Aged; Clinical Trials, Phase III as Topic; Hematoma, Subdural, Chronic; | 2022 |
Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial.
Topics: Activities of Daily Living; Aged; Clinical Trials, Phase III as Topic; Hematoma, Subdural, Chronic; | 2022 |
Effect of postoperative tranexamic acid on recurrence rate and complications in chronic subdural hematomas patients: preliminary results of a randomized controlled clinical trial.
Topics: Aged; Drainage; Hematoma, Subdural, Chronic; Humans; Postoperative Complications; Postoperative Peri | 2023 |
Letter to the editor: Effect of postoperative tranexamic acid on recurrence rate and complications in chronic subdural hematomas patients: preliminary results of a randomized controlled clinical trial.
Topics: Hematoma, Subdural, Chronic; Humans; Tranexamic Acid | 2023 |
Prospective Study on the Efficacy of Orally Administered Tranexamic Acid and Goreisan for the Prevention of Recurrence After Chronic Subdural Hematoma Burr Hole Surgery.
Topics: Administration, Oral; Aged; Antifibrinolytic Agents; Drugs, Chinese Herbal; Female; Follow-Up Studie | 2020 |
An open label randomized trial to assess the efficacy of tranexamic acid in reducing post-operative recurrence of chronic subdural haemorrhage.
Topics: Aged; Antifibrinolytic Agents; Female; Hematoma, Subdural, Chronic; Humans; Male; Neurosurgical Proc | 2020 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial.
Topics: Antifibrinolytic Agents; Clinical Protocols; Cognition; Double-Blind Method; Hematoma, Subdural, Chr | 2016 |
9 other studies available for tranexamic acid and Hematoma, Subdural, Chronic
| Article | Year |
|---|---|
Adjuvant oral tranexamic acid and reoperation after burr hole surgery in patients with chronic subdural hematoma: propensity score-matched analysis using a nationwide inpatient database.
Topics: Drainage; Hematoma, Subdural, Chronic; Humans; Inpatients; Propensity Score; Recurrence; Reoperation | 2023 |
The Outcome of Medical Management of Chronic Subdural Hematoma with Tranexamic Acid - A Prospective Observational Study.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Conservative Treatment; Female; Hematoma, S | 2020 |
Medical Management of Chronic Subdural Hematoma with Tranexamic Acid.
Topics: Antifibrinolytic Agents; Hematoma, Subdural, Chronic; Humans; Tranexamic Acid; Treatment Outcome | 2021 |
Reply to Letter to Editor.
Topics: Hematoma, Subdural, Chronic; Humans; Tranexamic Acid | 2021 |
Preventive role of tranexamic acid in post-operative recurrence of chronic subdural haemorrhage: Do we have sufficient evidence?
Topics: Antifibrinolytic Agents; Hematoma, Subdural, Chronic; Humans; Postoperative Period; Recurrence; Tran | 2021 |
Tranexamic acid for chronic subdural hematoma.
Topics: Drainage; Hematoma, Subdural, Chronic; Humans; Tranexamic Acid; Treatment Outcome; Trephining | 2021 |
A Case of Tranexamic Acid as Adjunctive Treatment for Chronic Subdural Hematoma with Multiple Recurrences.
Topics: Antifibrinolytic Agents; Combined Modality Therapy; Craniotomy; Hematoma, Subdural, Chronic; Humans; | 2017 |
Nonsurgical treatment of chronic subdural hematoma with tranexamic acid.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Brain; Combined Modality Therapy; Female; Hematoma | 2013 |
Nonsurgical treatment of chronic subdural hematoma with tranexamic acid.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Brain; Combined Modality Therapy; Female; Hematoma | 2013 |
Nonsurgical treatment of chronic subdural hematoma with tranexamic acid.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Brain; Combined Modality Therapy; Female; Hematoma | 2013 |
Nonsurgical treatment of chronic subdural hematoma with tranexamic acid.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Brain; Combined Modality Therapy; Female; Hematoma | 2013 |
[Effect of Gorei-san with tranexamic acid for preventing recurrence of chronic subdural hematoma].
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Hematoma, Subdura | 2012 |